Perpetual Ltd’s Outset Medical OM Stock Holding History

Perpetual Ltd’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-769	Closed	-$212K	–	498
2023 Q1	$212K	Buy	+769	New	+$282K	﹤0.01%	485
2020 Q3	$250K	Buy	+333	New	+$273K	0.02%	246

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Perpetual Ltd's OM Position: Q2 2023 in Review

Perpetual Ltd sold out of Outset Medical (OM) in Q2 2023, closing a stake of 769 shares — an estimated $212K sold.

Perpetual Ltd first reported a position in OM in Q3 2020 and held it in 2 quarters. The position peaked at $250K in Q3 2020. 154 funds tracked by Wall St. Rank hold OM as of Q2 2023.

Perpetual Ltd reported no remaining Outset Medical position as of Q2 2023 after selling out during the quarter.
Perpetual Ltd sold 769 Outset Medical shares in Q2 2023, an estimated $212K.
Perpetual Ltd first reported a position in Outset Medical in Q3 2020 and held it in 2 quarters.
Perpetual Ltd's Outset Medical position peaked at $250K in Q3 2020.
154 funds tracked by Wall St. Rank held Outset Medical as of Q2 2023.

Based on Perpetual Ltd's 13F filing for Q2 2023, filed 13 Jul 2023.